Absence of electrocardiographic left ventricular hypertrophy is associated with increased mortality after transcatheter aortic valve replacement.
Polydoros N KampaktsisAjayram V UllalRajesh V SwaminathanRobert M MinutelloLuke KimGeoffrey S BergmanDmitriy N FeldmanHarsimran SinghShing Chiu WongPeter M OkinPublished in: Clinical cardiology (2018)
The absence of ECG LVH was independently associated with increased mortality in patients undergoing TAVR. Baseline ECG may have an important prognostic role in these patients and could lead to further testing to evaluate for myocardial fibrosis or amyloidosis.
Keyphrases
- transcatheter aortic valve replacement
- aortic stenosis
- left ventricular
- ejection fraction
- aortic valve
- patients undergoing
- end stage renal disease
- heart rate variability
- heart rate
- chronic kidney disease
- newly diagnosed
- prognostic factors
- acute myocardial infarction
- mitral valve
- cardiac resynchronization therapy
- left atrial
- type diabetes
- blood pressure
- cardiovascular events
- cardiovascular disease
- risk factors
- coronary artery disease
- patient reported outcomes
- multiple myeloma
- atrial fibrillation